Comparison of IVF Outcomes Between PPOS and Antagonist Protocols in Women With PCOS

Who May Qualify: - Women aged 18-40 years - Diagnosed with polycystic ovary syndrome (PCOS) according to the modified Rotterdam criteria (2004) (≥2 of 3: oligo/anovulation, hyperandrogenism, or polycystic ovarian morphology on ultrasound) - Indicated for in vitro fertilization (IVF) due to PCOS alone or PCOS with other infertility factors (e.g., tubal factor, previous failed IUI) - Eligible for controlled ovarian stimulation for IVF - Husband/partner with normal sperm parameters or mild to moderate oligoasthenoteratozoospermia (OAT) - Willing and able to provide written willing to sign a consent form and comply with study procedures. Who Should NOT Join This Trial: - Uterine abnormalities that may impair implantation or pregnancy outcomes, including congenital uterine malformations, large fibroids distorting the uterine cavity, adenomyosis, or severe intrauterine pathology. - History of major ovarian or uterine surgery affecting ovarian reserve or uterine structure (e.g., ovarian cystectomy, endometriosis surgery, myomectomy, unilateral oophorectomy) - History of recurrent pregnancy loss (≥3 spontaneous miscarriages) - Known chromosomal abnormalities in either partner - Inability to adhere to study protocol or follow-up procedures Always talk to your doctor about whether this trial is right for you.